Study Defines Geographic Hot Spots of Early-Onset CRC Morality Among Women
November 27, 2020

These results emphasize the importance of defining patterns of variance in early-onset CRC survival in order to understand the impact of community health behaviors on early-onset CRC outcomes.

Phase 2 Trial Reports Positive Outcomes with Treatment Combination for Ovarian Cancer
November 27, 2020

A phase 2 trial found that the combination of pembrolizumab with bevacizumab and oral cyclophosphamide was well tolerated and demonstrated clinical benefit and durable treatment responses in patients with recurrent ovarian cancer.

Selinexor, Bortezomib, Dexamethasone Combination Effective for Patients with Multiple Myeloma
November 27, 2020

The phase 3 BOSTON study suggested that a once-per-week combination regimen of selinexor (Xpovio), bortezomib (Velcade), and dexamethasone (Ozurdex) is an effective treatment option for patients with multiple myeloma who have received 1 to 3 previous lines of therapy.

State-Level Lung Cancer Screening Rates Do Not Align with Lung Cancer Burden
November 26, 2020

This study found that state-level lung cancer screening rates were not aligned with disease burden, with the exception of Kentucky, which has supported comprehensive efforts to implement lung cancer screening.

STAR-CAP Suggested to be a Viable AJCC-Compliant Staging System for Prostate Cancer
November 26, 2020

According to the researchers, the high-quality evidence observed thus far supports the endorsement of this scoring system as a new staging system for prostate cancer.

Study Suggests AYAs Treated for AML Have High Risk of Developing Long-Term Complications
November 25, 2020

These results suggested that adolescent and young adult patients treated for acute myeloid leukemia have a high risk of developing long-term health complications.